OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

Charity Registration No. 800733

Company Registration No. 02229663 (England and Wales)

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION

IMPROVING LIVES BY SUPPORTING PROFESSIONALS IN THE DELIVERY OF KIDNEY CARE & RESEARCH

(A COMPANY LIMITED BY GUARANTEE)

ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) CONTENTS

Page
Trustees’ report 1 – 10
Independent auditor’s report 11 – 14
Statement of financial activities 15
Balance sheet 16
Statement of cash flows 17
Notes to the financial statements 18 - 30

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

TRUSTEES REPORT (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2025

The trustees, who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 December 2025. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019) and the Charities Act 2011.

The financial statements have been prepared in accordance with the accounting policies set out in the notes to the financial statements and comply with The Renal Association's governing document, the Companies Act 2006 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019).

OBJECTIVES AND ACTIVITIES

Objectives and aims

“Improving lives by supporting professionals in the delivery of kidney care and research”

The UK Kidney Association (UKKA) is the leading professional body for the UK kidney community. We welcome members working in clinical renal care, treating and caring for people with kidney disease, those working in research, or related sciences and fields and all allied healthcare professionals.

We are transforming the way kidney care and research is delivered in the UK and beyond. Our decisions have been and will continue to be guided by our values:

To achieve this, we will value and support all our members from all the professions that make us the UKKA. The UKKA can only be successful if each of the professional groups feel they have a valued place within it. It is also crucial we play our part within the kidney community working with partner charities, both patient and professional facing, along with statutory bodies at a national and regional level. These aims have required new structures and ways of working but are built on firm foundations of good governance including an active and engaged group of trustees, a patient and professional council supporting and shaping strategic decisions along with an experienced executive.

ISN Fellowship Program

The ISN Fellowship Program provides an opportunity for UK units to host trainees from the developing world for up to 12 months. Since 2002, the UK has hosted 30 ISN fellows based in 17 centres through the generous support of the ISN, Kidney Research UK and the UK Kidney Association. There is presently no ISN fellow in training.

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

TRUSTEES REPORT (CONTINUED)(INCLUDING DIRECTOR’S REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2025

Strategic report
Achievements and performance
Meetings
24 January 2025: SpR Club Webinar – Taster course in Nephrology - online
30 – 31 January 2025: BAPN/PNNG Winter Meeting – held in Birmingham
19 March 2025: CD Forum – held in Birmingham
26 – 27 April 2025: SpR Spring Meeting – held in York
8 – 9 May 2025: GRID Meeting – held in Southampton
10 – 12 June 2025: UKKW – held in Bournemouth
5 July 2025: Renal Crash Course – held in Bristol
20 – 21 September 2025: SpR Autumn Meeting – held in Cambridge
2 October 2025: CD Virtual Forum - online
11 – 12 October 2025: RPG Conference – held in Manchester
18 October 2025: ANC Training Day – held in Birmingham
22 October 2025: Informatics Meeting - online
3 November 2025 UKKA Corporate day – held in Birmingham
5 November 2025: PNNG Virtual - online
12 November 2025: Sustainable Kidney Care – online
18 November 2025: Renal Stones Webinar (SpR) – online
22 November 2025: ING Residential Course – held in Reading
27 November 2025: Grid Training Day – held in Newcastle

Monthly webinars and international case discussions.

For further information on the full achievements and performance for 2025, please see our annual AGM report available on our website.

Renal Association awards and prizes

Raine Award

The Raine award is made annually to a relatively junior member who has made a significant contribution to research. In 2025 this was awarded to Dr Daniyal Jafree.

Walls Bursaries

The John Walls Bursary enables two members, a clinician and non-clinician, to spend short periods at other centres, generally outside the UK, to learn new laboratory techniques or gain new clinical skills. In 2025 no awards were offered.

Lockwood Award

The Lockwood Award is awarded to help members to present work and combine this with a visit to a collaborating laboratory or clinical nephrology unit overseas. In 2025 no awards were offered.

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

TRUSTEES REPORT (CONTINUED)(INCLUDING DIRECTOR’S REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2025

Financial review

Where our income came from?

Our total income for 2025 was £6,471,641 (2024: £5,192,358) an increase of 25%.

Income from charitable activities: The majority of income is sourced from capitation fees which accounted for £2,752,897 (2024: £2,580,919). Other income consists mainly of project work, sponsorship for events and a cross charge for the secretariat team (see note 4). The additional other income in 2025 derived from a successful UK Kidney Week and a substantial increase in RaDaR project work which continues to increase as awareness and utilisation of the database expands. Income from memberships increased to a total of £209,206 (2024: £149,889), following successful resolution of previous system issues and a movement to a tier-based offer. Income from scientific meetings increased to £654,357 (2024: £610,261). Recognising the potential risk associated with UKKW 2026, due to its proximity to a major continental conference, we strategically planned to generate sufficient surplus in 2025 to mitigate any impact for the following year.

Income from donations, legacies and grants increased to £501,196 (2024: £291,454), supported by new collaborative initiatives such as the Advanced Kidney Care programme and early CKD educational projects.

Income from investments: Decreased to £61,179 (2024: £77,858).

Where was it spent?

Our total expenditure for 2025 was £5,150,188 (2024: £4,683,053) an increase of 10%.

Direct costs: We spent £4,972,233 in 2025 (2024: £4,438,666). Management costs increased to £2,612,461 (2024: £2,367,849) reflecting employer NI increases and additional staffing required to deliver funded project work. This also increased our human resources spend to £243,626 (2024: £164,752) as we supported our staff with travel and training as required. We continue to invest in our IT infrastructure to ensure the security and integrity of our organisation, in 2025 we spent £287,592 (2024: £247,857). Our meeting costs increased in line with the increased number of delegates at our events and other expanded event activity. We also invested funds into the infrastructure of our leased building, and we purchased a new membership system to resolve the prior issues.

Support costs: We spend £175,995 in 2025 (2024: £234,087).

Grants payable decreased to £1,960 (2024: £10,300), due to a delay in issuing one grant.

For further information please see notes 6-13.

Financial position

The UK Kidney Association had an overall surplus for 2025 of £1,321,066 (2024: £509,294). The association had an overall surplus of £370,676 (2024: £153,192) and the UK Renal Registry had a surplus of £950,390 (2024: £356,102). At the end of 2025 total assets held by the UKKA were £5,578,570 (2024: £4,257,504).

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

TRUSTEES REPORT (CONTINUED)(INCLUDING DIRECTOR’S REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2025

Reserves policy

The trustees of the UK Kidney Association (UKKA) are obligated to act in the interests of the charity and protect and safeguard the assets with care and skill and in an accountable manner. The reserves policy has been developed by the trustees to explain to the stakeholders why we hold a particular amount of reserves, to demonstrate that finances are being properly managed and provide assurance of our overall resilience and ability to cover the winding up costs of the charity should that become necessary.

The benchmark for 2025 was to hold a minimum of £3 million to a maximum of £7 million in reserve. All reserves are held either in short to medium term investments or as cash in hand at the bank. The reserves at 31/12/2025 were £5,578,570 (2024: £4,257,504) which was within the benchmarks. Overall, the UKKA is very secure. The reserves held are sufficient to cover 12 months operating costs and this should be maintained. These reserves held fluctuate throughout the year due to the seasonality of our income however a minimum of one year of staff salaries must be always maintained, which we adhered to for 2025.

Investment policy

The trustees are governed by the Trustee Act 2000 and invest to ensure the best financial return with an acceptable level of risk and whilst still maintaining liquidity. All funds have a minimum credit rating of A- and have an ethical policy which excludes investment in pharmaceutical companies, tobacco companies and companies involved in the production or distribution of alcohol.

Fundraising

The charity does not engage in significant public fundraising.

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

TRUSTEES REPORT (CONTINUED)(INCLUDING DIRECTOR’S REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2025

Organisational development and future plans

Developing Leadership:

Research:

Workforce:

Education:

Quality Improvement & Assurance:

Shaping Services:

Structure, governance and management

Governing document

The charity is controlled by its governing document, a deed of trust, and constitutes a limited company, limited by guarantee, as defined by the Companies Act 2006. The UK Kidney Association is a company limited by guarantee by its Memorandum and Articles of Association, revised in November 2020. It is registered as a charity with the Charity Commission.

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

TRUSTEES REPORT (CONTINUED)(INCLUDING DIRECTOR’S REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2025

Key management remuneration

The Key Management Personnel of the Charity consists of the Chief Executive Officer, Head of Operations and the Head of Finance. Where such individuals or those closely connected with them are remunerated by the Charity, their pay is set by a standard salary-band matrix.

Related parties

None of the trustees receive remuneration or other benefits from their work with the charity. As per the amendment in the articles, the payment of reasonable and proper fees to the employer of the President is now permitted. No payments to a president, other than reasonable expense claims, have been made to date.

Related party transactions have been disclosed in note 22.

Recruitment and appointment of new trustees

The Trustees of the Association are appointed in a general meeting, and each individual appointment shall be for a term in office as follows:

Position Appointed by Term Role
President x 2 Elected position
(ballot of all
members)
Will normally serve for five
years in total; one as
President-Elect, followed by
two or three years as
President, followed by two or
one further years as Past
President.
Chair of the Trustees. Overall strategic
leadership of the Association, Chair the
board of Trustees, UKKA Council and
Professional Council.
Past President See President See President. Assists the President in carrying out his/her
duties and responsibilities. Chairs
Governance and Nominations Committee.
President Elect See President See President. See President.
Clinical Vice President x
2

Elected position
(ballot of all
members)
Will normally serve for three
years and a maximum of four
years.
Chair of the Clinical Affairs Board, which co-
ordinates the joint functions of the: Clinical
Services Committee; Clinical Practice
Guidelines Committee; Patient Information
Committee; Kidney Patient Safety
Committee and the Sustainable Kidney
Care Committee.
Academic Vice
President x 2
Elected position
(ballot of all
members)
Will normally serve for three
years and a maximum of four
years.
Chair of the Academic Affairs Board, which
co-ordinates the joint functions of the:
International Committee, Education and
Training Committee, Research Committee,
Renal Scientists Committee and the Rare
Diseases Committee.
Membership & Policy
Secretary x 2
Appointed by the
trustees
Will normally serve for three
years and a maximum of four
years.
Membership enquiries, general enquiries,
communication with the membership,
planning of meetings, coordinates UKKA
responses to consultations.
Trustee with Financial
Responsibility
Appointed by the
trustees
Will normally serve for three
years and a maximum of four
years.
Accounts, contracts, budgeting. Chairs the
Finance and Risk Committee.
President of the British
Association for
Paediatric Nephrology
(BAPN)
Elected position
(ballot of all
paediatric members)

Will normally serve for a
maximum of three years.
Chairs Paediatric Affairs Committee.
Non-member trustee Appointed by the
trustees
Will normally serve for three
years and a maximum of six
years.
Member of the Finance and Risk Committee
and Governance and Nominations
Committee.
Appointed member
trustees
Appointed by the
trustees
Will normally serve for three
years and a maximum of four
years.
Roles and titles to be appointed by the
trustees.

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT (CONTINUED)(INCLUDING DIRECTOR’S REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2025

Induction and training of new trustees

Newly elected members are advised of their responsibilities as directors and trustees via a job description. They have a period of hand-over with their predecessor before formally taking up the role.

Risk Management

The trustees have a duty to identify and review the risks to which the charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error. The Finance and Risk Committee meet quarterly to review any risks, to ensure our systems are robust and to report on this risk to the trustee board. Good governance is imbedded in our organisation’s culture and structure which allows us to react swiftly when necessary. The current high level risks for the charity are as follows - the migration of NHS England into PH England and how this could impact trusts and the registry and secondly our capacity to take on new work. To mitigate these risks, we are collaborating with key decision makers within office and to improve capacity we have taken the decision to invest in four new members of staff in 2026.

Organisational structure

Founded in 1950, the UK Kidney Association is led by the Board of Trustees who work closely with appointed officers and members of the UKKA Council. The board of trustees meets regularly to direct the affairs of the Charity and consult representatives from other related organisations. The Finance & Risk and Governance & Nomination Committees consider their areas of focus in great detail and report recommendations and risks to the Board of Trustees. Development and management of specific clinical and academic activities is delegated to sub-committees who report their proceedings to the Clinical AND Academic Affairs Committees.

Committees and other bodies

The Clinical and Academic Affairs Boards coordinate the activities of the following committees:

Committee Name Chair
Clinical Services Committee Dr Marie Condon
Clinical Practice Guidelines Committee Dr Mark Devonald and Ms Andrea Devaney
Patient Information Committee Dr Yincent Tse
Patient Safety Committee Dr Katy Jones and Ms Karen Jenkins
Sustainable Kidney Care Committee Dr Suren Kanagasundaram and Ms Gloria Munoz-
Figueroa
International Committee Dr Yusuf Jinadu
Rare Diseases Committee Prof Danny Gale
Education and Training Committee Dr Shalabh Srivastava

Public Benefit Statement

The trustees ensure that all activities and future plans are in line with the Renal Association’s aims and that these take into account the Charities Commission’s guidance on public benefit. The trustees confirm that they have complied with the duty in section 17(5) of the Charities Act 2011 to have regard to the Charity Commission's general guidance on public benefit, 'Charities and Public Benefit'. The charitable purposes of the Association are set out in its objectives on page 1.

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

TRUSTEES REPORT (CONTINUED)(INCLUDING DIRECTOR’S REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2025

REFERENCE AND ADMINISTRATIVE DETAILS

Registered Company number

02229663 (England and Wales)

Registered Charity number

800733

Registered office

Brandon House Building 20a1, Southmead Road, Filton, Bristol, BS34 7RR

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

TRUSTEES REPORT (CONTINUED)(INCLUDING DIRECTOR’S REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2025

Trustees

President Dr Katie Vinen Consultant Nephrologist
President MDT Ms Claire Morlidge Consultant Pharmacist
Past President Prof Paul Cockwell
(Resigned August 2025)
Professor of Nephrology
Trustee with Financial Responsibility Prof Timothy Bowen Professor of Matrix & Molecular Biology
Membership and Policy Secretary Dr Bhavna Pandya
(Appointed August 2025)
Consultant Nephrologist
Membership and Policy Secretary Prof Alan Salama
(Resigned September 2025)
Professor of Nephrology
Membership and Policy Secretary Ms Linda Tarm Senior Project Manager
Co-Academic Vice President Prof John Sayer Professor of Nephrology
Co-Academic Vice President Dr Kathrine Parker Pharmacist
Co-Clinical Vice President Prof James Burton Professor of Nephrology
Co-Clinical Vice President Ms Lisa Ancliffe Occupational Therapist
BAPN President Prof Stephen Marks Professor of Paediatric Nephrology
Non-member Trustee Ms Laura Meaden Acquisitions Director
Non-member Trustee Mr Mark Froud Retired Professional

The Company Directors /Trustees met formally four times in 2025 on: 21 March, 9 June, 19 September and 12 December. They were additionally in close contact throughout the year, by regular email, telephone communications and scheduled fortnightly Trustee meetings.

Auditors

Gravita Audit Western Limited, 2[nd] Floor South One Castle Park, Tower Hill, Bristol, BS2 0JA

Accountants

Evans & Partners Ltd, 9 Bank Road, Kingswood, Bristol, BS15 8LS The accountants will be proposed for re-appointment at the forthcoming Annual General Meeting

Bankers

Bank of Scotland Metro Bank Tellaroo Flagstone

Solicitors

Blake Morgan, One Central Square, Cardiff, CF10 1FS

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

TRUSTEES REPORT (CONTINUED)(INCLUDING DIRECTOR’S REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2025

Statement of Trustees responsibilities

The trustees (who are also the directors of The Renal Association for the purposes of company law) are responsible for preparing the Report of the Trustees and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland".

Company law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing those financial statements, the trustees are required to select suitable accounting policies and then apply them consistently; observe the methods and principles in the Charity SORP;

The trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the charitable company and to enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

In so far as the trustees are aware:

This report has been prepared in accordance with the special provisions of Part 15 of Companies Act 2006 relating to small companies.

Report of the trustees, incorporating a strategic report, approved by order of the board of trustees, as the company directors, on .................... and signed on the board's behalf by: 07/09/2026

.............................. Professor T Bowen

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

INDEPENDENT AUDITORS’ REPORT

TO THE TRUSTEES OF THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION

Opinion

We have audited the financial statements of The Renal Association (the 'charitable company') for the year ended 31 December 2025 which comprise the Statement of Financial Activities, the Balance Sheet, the Cash Flow Statement and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In our opinion, the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The trustees are responsible for the other information. The other information comprises the information included in the Annual Report, other than the financial statements and our Report of the Independent Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

INDEPENDENT AUDITORS’ REPORT

TO THE TRUSTEES OF THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Report of the Trustees.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the Trustees' Responsibilities Statement, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the charitable company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) INDEPENDENT AUDITORS’ REPORT

TO THE TRUSTEES OF THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION

Our responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Independent Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities outlined above, to detect material misstatements in respect of irregularities, including fraud. We obtained an understanding of the legal and regulatory framework applicable to the charitable company, including those areas that could reasonably be expected to have a material effect on the financial statements. The most significant were identified as The Companies Act 2006, UK GAAP (FRS102), The Charities SORP (FRS102) and The Charities Act 2011.

We considered the extent of compliance with those laws and regulations as part of our procedures on the related financial statements. Our audit procedures included:

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Independent Auditors.

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

INDEPENDENT AUDITORS’ REPORT

TO THE TRUSTEES OF THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION

Use of our report

This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Matthew Bracher BSc FCA (Senior Statutory Auditor) for and on behalf of Gravita Audit Western Limited Chartered Accountants and Statutory Auditors 2[nd] Floor South One Castle Park

Tower Hill Bristol BS2 0JA

07/09/2026

Date: .........................

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 DECEMBER 2025

Designated
Designated registry and Restated
association research Total Total
funds funds 2025 2024
Income from: Notes £ £ £ £
Donations, legacies and grants 2 163,197 337,999 501,196 291,454
Charitable activities 3 1,568,688 4,340,578 5,909,266 4,823,046
Investments 5 11,693 49,486 61,179 77,858
-------------- -------------- -------------- --------------
Total income 1,743,578 4,728,063 6,471,641 5,192,358
-------------- -------------- -------------- --------------
Expenditure on:
Charitable activities
Expenditure of charitable activities 6 1,496,261 3,653,927 5,150,188 4,683,053
--------------- -------------- -------------- --------------
Net income for the year/
Net incoming resources 247,317 1,074,136 1,321,453 509,305
Other recognised gains and losses
Other gains or losses 13 - (387) (387) (11)
Transfers between funds 123,359 (123,359) - -
-------------- -------------- -------------- --------------
Net movement in funds 370,676 950,390 1,321,066 509,294
Fund balances at 1 January 2025 993,014 3,264,490 4,257,504 3,748,210
-------------- --------------- -------------- --------------
Fund balances at 31 December 2025 1,363,690 4,214,880 5,578,570 4,257,504
======== ======== ======== ========

The statement of financial activities includes all gains and losses recognised in the year.

All income and expenditure derive from continuing activities.

The statement of financial activities also complies with the requirements for an income and expenditure account under the Companies Act 2006.

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

BALANCE SHEET

AS AT 31 DECEMBER 2025

Registry and
Association research Total Total
funds funds 2025 2024
Notes £ £ £ £
Fixed Assets
Tangible assets 15 - 51,986 51,986 19,524
Current assets
Debtors 16 496,366 823,703 1,320,069 814,799
Cash at bank and in hand 1,154,204 3,878,371 5,032,575 4,055,936
-------------- -------------- -------------- --------------
1,650,570 4,702,074 6,352,644 4,870,735
Creditors: amounts falling due within
one year
17 (286,880) (539,180) (826,058) (632,755)
-------------- -------------- -------------- --------------
Net current assets 1,363,690 4,162,894 5,526,584 4,237,980
-------------- -------------- -------------- --------------
Total assets less current liabilities 1,363,690 4,214,880 5,578,570 4,257,504
======== ======== ======== ========
Income funds
Registry and research fund 4,214,880 3,264,490
Association fund 1,363,690 993,014
-------------- --------------
5,578,570 4,257,504
======== ========

The company is entitled to the exemption from the audit requirement contained in section 477 of the Companies Act 2006, for the year ended 31 December 2025, although an audit has been carried out under section 144 of the Charities Act 2011.

The trustees are responsible for ensuring that the charity keeps accounting records which comply with section 386 of the Act and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its incoming resources and application of resources, including its income and expenditure, for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

07/09/2026

The financial statements were approved by the Trustees on .........................

----- Start of picture text -----
..............................
----- End of picture text -----

.............................. Professor T Bowen Trustee

Company Registration No. 02229663

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 DECEMBER 2025

2025 2025 2024 2024
Notes £ £
£
£
Cash flows from operation activities
Cash generated from operations 23 966,137 636,499
Cash flows from investing activities
Purchase of tangible assets (48,622) (10,028)
Interest received 61,179 77,858
Interest paid (2,055) -
Net cash generated from investing activities 10,502 67,830
------------- -------------
Net increase in cash and cash equivalents 976,639 704.329
Cash and cash equivalents at beginning of year 4,055,936 3,351,607
-------------- --------------
Cash and cash equivalents at end of year 5,032,575 4,055,936
======== ========
Notes to the Cash Flow Statement
Analysis of changes in net debt At 01/01/25 Cash flow At 31/12/25
Net cash
Cash at bank and in hand 4,055,936 976,639 5,032,575
-------------- ------------ --------------
Total 4,055,936 976,639 5,032,575
======== ======= ========

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

1 Accounting Policies

Charity information

The Renal Association is a private company limited by guarantee incorporated in England and Wales. The registered office is Brandon House Building 20a1, Southmead Road, Bristol, BS34 7RR.

1.1 Accounting convention

The financial statements of the charitable company, which is a public benefit entity under FRS102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the Renal Association. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2 Going concern

The accounts have been prepared on the assumption that the charitable company is able to continue as a going concern.

The charitable company holds unrestricted, general reserves of £1,363,690, designated reserves that can be drawn down if necessary of £4,214,880 and a cash balance of £5,032,575. The trustees consider that the charitable company has sufficient cash reserves to continue as a going concern for a period of at least 12 months from the date on which these financial statements are approved.

1.3 Charitable funds

Association funds are used in accordance with the charitable objectives at the discretion of the trustees.

Certain funds will be designated for specific purposes. The Executive Committee have decided that setting aside funds in this way is a useful financial discipline which will help the charity make the best use of its resources, even though there is no legal force to the designation.

Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. Further explanation of the nature and purpose of each fund is included in note 19 (movement in funds).

1.4 Income

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably. Full provision is made for subscriptions and sponsorships received in advance. All voluntary income is included in income on a receipt basis.

Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods and services provided in the normal course of business, net of discounts, VAT and other sales related taxes. Capitation fees, grants and scientific meetings are recognised on a receivable basis.

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

1 Accounting policies

(Continued)

1.5

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Grants offered subject to conditions which have not been met at the year-end date are noted as a commitment but not accrued as expenditure.

1.6 Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computer equipment 33% on cost Fixtures and fittings 25% on cost

Fixed assets are capitalised when the initial cost exceeds £500.

1.7 Financial instruments

The charity has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments. Financial instruments are recognised when the charity becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost. Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the charity transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Basic financial liabilities

Basic financial liabilities, including trade and other creditors are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Debt instruments are subsequently carried at amortised cost, using the effective interest rate method. Financial liabilities are derecognised when, and only when, the charity's contractual obligations are discharged, cancelled, or they expire.

1.8 Taxation

The charity is exempt from corporation tax on its charitable activities.

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

1 Accounting policies

(Continued)

1.9 Employee benefits

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.10 Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.11 Leases

Rentals payable and receivable under operating leases are charged to the SoFA on a straight line basis over the period of the lease.

1.12 Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation are included in net income/(expenditure) for the period.

1.13 Prior period adjustment

2 Donations, legacies and grants

Registry and
Association research Total Total
funds funds 2025 2024
£ £ £ £
Grants 162,248 337,375 499,623 215,245
Legacies - - - 70,000
Donations 949 624 1,573 6,209
------------ ------------ ------------ ------------
163,197 337,999 501,196 291,454
======= ======= ======= =======
Grants received, included in the above are as follows 2025 2024
£ £
Association funds 162,248 39,752
Registry and research funds 337,375 175,493
----------- ------------
499,623 215,245
======= =======

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

Draft Financial Statements

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

3 Income from charitable activities

Capitation fees –
Renal Registry
Subscriptions
– Renal
Association
Scientific
meetings -
Renal
Association
Other income
– Renal
Association
Other income –
Renal Registry
Total
2025
Restated
Total
2024
(See note 4) (See note 4)
£ £ £ £ £ £ £
Income from charitable activities 2,752,897 209,206 654,357 705,125 1,587,681 5,909,266 4,823,046
======== ======= ======= ======= ======== ======== ========
Analysis by fund
Association funds - 209,206 654,357 705,125 - 1,568,688
Registry and research funds 2,752,897 - - - 1,587,681 4,340,578
-------------- -------------- -------------- -------------- -------------- --------------
2,752,897 209,206 654,357 705,125 1,587,681 5,909,266
======== ======== ======== ======== ======== ========
For the year ended 31 December 2024
(Restated)
Association funds - 149,889 610,261 604,622 - 1,364,772
Registry and research funds 2,580,919 - - - 877,355 3,458,274
-------------- -------------- -------------- -------------- -------------- --------------
2,580,919 149,889 610,261 604,622 877,355 4,823,046
======== ======== ======== ======== ======== ========

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

4 Other charitable activity income

Registry and Registry and
Association research Association research Restated
funds funds Total funds funds Total
2025 2025 2025 2024 2024 2024
£ £ £ £ £ £
Events 630,950 - 630,950 549,913 600 550,513
Project fees - 1,300,427 1,300,427 - 376,020 376,020
Other income 74,175 287,254 361,429 54,709 500,735 555,444
------------- ------------- ------------- ------------- ------------- -------------
Total other
income
705,125 1,587,681 2,292,806 604,622 877,355 1,481,977
======== ======== ======== ======== ======== ========

5 Investments

Registry and Registry and Registry and
Association research
Total
Association
research

Total
funds funds
2025
funds
funds

2024
£ £
£
£ £
£
Interest receivable
11,693
49,486
61,179
9,458
68,400

77,858
====== ====== ====== ======
======
======
Charitable activities costs
Grant funding
of activities Direct costs Support costs Totals
(See note 7) (See note 8) (See note 9) 2025
£ £ £ £
Expenditure of charitable activities 1,960 4,972,233 175,995 5,150,188
===== ======== ======= ========
Restated
Totals
2024
£ £ £ £
Expenditure of charitable activities 10,300 4,438,666 234,087 4,683,053
====== ======== ======= ========

6 Charitable activities costs

The total grants paid to individuals during the year was as follows:

2025 2024
£ £
Individual grants 1,960 10,300
====== ======

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

8 Direct costs
Information Human Legal & Total
Other
Management
Technology Resources Professional 2025
£ £ £ £ £ £
Expenditure of
charitable activities 682,213 2,612,461 287,592 243,626 1,146,341 4,972,233
=======
========
======= ======= ======== ========
Restated
Information Human Legal & Total
Other
Management
Technology Resources Professional 2024
£ £ £ £ £ £
Expenditure of
charitable activities 662,870 2,367,849 247,857 164,752 995,338 4,438,666
=======
========
======= ======= ======== ========
Other Registry and Registry and
Restated
Association research Total Association research
Total
funds funds 2025 funds funds
2024
£ £ £ £ £
£
Honorarium 1,300 1,460 2,760 2,260 805
3,065
Meeting room costs 635,764 43,689 679,453 615,325 44,480
659,805
----------- --------- ----------- ----------- -----------
-----------
637,064 45,149 682,213 617,585 45,285
662,870
======= ======= ======= ======= =======
=======
Management Registry and Registry and Restated
Association research Total Association research Total
funds funds 2025 funds funds 2024
£ £ £ £ £ £
Wages - 2,138,162
2,138,162
- 1,973,362 1,973,362
Social security - 286,731 286,731 - 220,971 220,971
Pensions - 131,724 131,724 - 118,617 118,617
Training and
development
- 55,844 55,844 - 54,899 54,899
--------- -------------- ------------- --------- -------------- --------------
- 2,612,461
2,612,461
- 2,367,849 2,367,849
===== ========
========
===== ======== ========
Information Technology Registry and Registry and
Restated
Association
research

Total

Association
research
Total
funds
funds

2025

funds

funds

2024
£ £
£

£

£

£
Computer, storage and
advertising
54,665
232,927

287,592

703

247,154

247,857
======
=======

=======

======

=======

=======

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

8 Direct costs (Continued) (Continued)
Human Resources Registry and Registry and Restated
Association research Total Association research Total
funds funds 2025 funds funds 2024
£ £ £ £ £ £
Travel expenses 90,832 152,795 243,627 50,015 114,738 164,753
====== ======= ======= ====== ======= =======
Legal & Professional Registry and Registry and Restated
Association research Total Association research Total
funds funds 2025 funds funds 2024
£ £ £ £ £ £
Legal & professional
fees
295,990 462,732 758,722 306,963 321,441 628,404
Secretariat costs 387,619 - 387,619 366,934 - 366,934
------------ ------------ ------------ ------------ ------------ ------------
683,609 462,732 1,146,341 673,897 321,441 995,338
======= ======= ======= ======= ======= =======
9 Support costs
Total
Finance Other Governance 2025
£ £ £ £
Expenditure of charitable activities 1,062 152,487 22,446 175,995
===== ======= ====== =======
Restated
Total
Finance Other Governance 2024
£ £ £ £
Expenditure of charitable activities 1,356 208,787 23,944 234,087
===== ======= ====== =======
Finance Registry and Registry and Restated
Association research Total Association research Total
funds funds 2025 funds funds 2024
£ £ £ £ £ £
Bank charges 263 799 1,062 694 662 1,356
==== ==== ===== ==== ==== =====

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

9
Support costs
(Continued) (Continued)
Other Registry and Registry and Restated
Association research Total Association research Total
funds funds 2025 funds funds 2024
£ £ £ £ £ £
Office costs 127,899 - 127,899 139,277 - 139,277
Postage and stationery 1,386 4,986 6,372 1,113 3,573 4,686
Depreciation of
tangible fixed assets 15,916 245 16,161 24,236 588 24,824
Bad debts - 40,000 - 40,000
Late payment tax
charges
2,055 - 2,055 - - -
------------ --------- ----------- ---------- ---------- -----------
147,256 5,231 152,487 204,626 4,161 208,787
======= ===== ====== ====== ====== ======
Governance costs Registry Registry
and and Restated
Association research
Total
Association research Total
funds funds
2025
funds funds 2024
£ £
£
£ £ £
Trustees’ expenses 4,811 -
4,811
6,484 - 6,484
Auditor’s remuneration 7,000 -
7,000
6,801 - 6,801
Accountancy costs 10,635 -
10,635
10,659 - 10,659
----------- ---------
----------
---------- ---------- ----------
22,446 -
22,446
23,944 - 23,944
====== =====
======
====== ====== ======

10 Employees

The average monthly number employees during the year was:

2025 2024
Number Number
50 48
===== ======
Restated
Employment costs 2025 2024
£ £
Wages and salaries 2,138,162 1,973,362
Social security costs 286,731 220,971
Other pension costs 131,724 118,617
-------------- --------------
2,556,617 2,312,950
======== ========

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

10 Employees (Continued)

The number of employees whose annual remuneration was more than £60,000 is as follows:

2025 2024
Number Number
Employees earning between £60,000 - £70,000 1 -
Employees earning between £70,000 - £80,000 - 1
Employees earning between £80,000 - £90,000 1 -
Employees earning between £150,000 - £160,000 1 1
--------- ---------
3 2
===== =====
Remuneration of key management personnel
The remuneration of key management personnel is as follows:
2025 2024
£ £
Aggregate compensation 359,627 274,387
======= =======
11
Trustees’ remuneration and benefits

Trustees expenses are paid with accordance to The Renal Association expense claim policy. In 2025 7 trustees were reimbursed expenses totaling £4,811 (2024: £6,484 reimbursed to 8 trustees).

King’s College Trust and East Herts, the employers of two trustees (Katie Vinen and Clare Morlidge) were paid 0.1FTE in 2024.

12 Taxation

The charity is exempt from taxation on its activities because all its income is applied for charitable purposes.

13 Other gains or losses

2025 2024
£ £
Foreign exchange losses 387 11
===== =====

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

14 STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2024

Registry and Restated
Association research Total
funds funds funds
£ £ £
Income from:
Donations and legacies 115,961 175,493 291,454
Charitable activities 1,364,772 3,458,274 4,823,046
Investments 9,458 68,400 77,858
Other income - - -
-------------- -------------- --------------
Total income 1,490,191 3,702,167 5,192,358
-------------- -------------- --------------
Expenditure on:
Charitable activities
Expenditure of charitable activities 1,381,300 3,301,753 4,683,053
Other recognised gains and losses - (11) (11)
Transfers between funds 44,301 (44,301) -
----------- ------------ ------------
Net income/(expenditure) 153,192 356,102 509,294
Reconciliation of funds
Total funds brought forward 839,822 2,908,388 3,748,210
------------ -------------- --------------
Total funds carried forward 993,014 3,264,490 4,257,504
======= ======== ========
15
Tangible fixed assets
Computer Fixtures and
equipment fittings Total
£ £ £
Cost
At 1 January 2025 168,386 59,454 227,840
Additions 1,387 47,235 48,622
----------- ----------- -----------
At 31 December 2025 169,773 106,689 276,462
----------- ----------- -----------
Depreciation and impairment
At 1 January 2025 148,862 59,454 208,316
Depreciation charged in the year 15,176 984 16,160
----------- ----------- -----------
At 31 December 2025 164,038 60,438 224,476
----------- ----------- -----------
Carrying amount
At 31 December 2025 5,735 46,251 51,986
====== ====== ======
At 31 December 2024 19,524 - 19,524
====== ====== ======

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

16 Debtors
2025 2024
Amounts falling due within one year: £ £
Trade debtors 790,128 420,640
Other debtors 6,064 10,340
Prepayments and accrued income 523,877 383,819
-------------- ------------
1,320,069 814,799
======== =======
17 Creditors
2025 2024
Amounts falling due within one year: £ £
Other taxation and social security 85,581 69,572
Trade creditors 252,513 155,343
Other creditors 46,438 27,141
Accruals and deferred income 441,526 380,699
------------ ------------
826,058 632,755
======= =======

18 Retirement benefit schemes

Defined contribution schemes

The charity operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the charity in an independently administered fund.

The charge to profit or loss in respect of defined contribution schemes was £131,724 (2024 : £118,617).

At the year-end there were pensions of £19,187 (2024: £435) deducted from salaries but not yet paid over to the pension scheme administrator.

19 Movement in funds

9
Movement in funds
At 01/01/25 Net movement
in funds
At 31/12/25
£ £ £
Association funds
Renal Association 993,014 370,676 1,363,690
Registry and research funds
Renal Registry 3,264,490 950,390 214,880
-------------- -------------- --------------
Total funds 4,257,504 1,321,066 5,578,570
======== ======== ========

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

19
Movement in funds
(Continued)
At 01/01/24 Net movement
in funds
At 31/12/24
£ £ £
Association funds
Renal Association 839,822 153,192 993,014
Registry and research funds
Renal Registry 2,908,388 356,102 3,264,490
-------------- -------------- --------------
Total funds 3,748,210 509,294 4,257,504
======== ======== ========

Net movement in funds, included in the above are as follows:

Movement
Incoming Resources in funds
resources expended Transfers 2025
£ £ £ £
Association funds
Renal Association 1,743,578 (1,496,261) 123,359 370,676
Registry and research funds
Renal Registry 4,728,063 (3,654,314) (123,359) 950,390
-------------- -------------- ----------- --------------
Total funds 6,471,641 (5,150,575) - 1,321,066
======== ======== ======= ========
Movement
Restated Incoming Resources in funds
resources expended Transfers 2024
£ £ £ £
Association funds
Renal Association 1,490,191 (1,381,300) 44,301 153,192
Registry and research funds
Renal Registry 3,702,167 (3,301,764) (44,301) 356,102
-------------- -------------- ----------- --------------
Total funds 5,192,358 (4,683,064) - 509,294
======== ======== ======= ========

Fund

Associated fund

This fund represents the free reserves of the charity.

Registry and research fund

This fund represents amounts which are committed to the UK Renal Registry and have been set aside by the Executive Committee to help the charity make best use of its resources.

Transfer of funds

During the year there was a transfer of £123,359 between association and registry funds. This related to the transfer of the accountancy costs, interest received in the investments bank, VAT balance and amounts held at year-end for cross charge invoices.

Docusign Envelope ID: 6C81734F-1297-8D1C-81C7-29259C61A987

THE RENAL ASSOCIATION T/A THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

20 Share capital

The charitable company is limited by guarantee and therefore has no share capital. Each member's guarantee is limited to £1.

21 Operating lease commitments

The following operating lease payments are committed to be paid as follows:

Land and buildings 2025 2024
£ £
Within one year 48,600 48,600
Between two and five years 133,600 182,200
In over five years - -
----------- -----------
182,200 230,800
======= =======
22
Related party transactions

There were no related party transactions in 2025 (2024: £Nil).

23 Cash generated from operations

2025 2024
£ £
Surplus for the year 1,321,453 509,305
Adjustments for:
Investment income recognised in statement of financial activities (61,179) (77,858)
Foreign exchange differences (387) (11)
Depreciation and impairment of tangible fixed assets 16,160 24,824
Interest expense 2,055 -
Movements in working capital:
(Increase)/decrease in debtors (505,270) (10,322)
Increase/(decrease) in creditors 193,303 190,561
----------- -----------
Cash generated from operations 966,137 636,499
======= =======